Press Releases Ypsomed Group

Burgdorf - Ypsomed, the leading independent developer and manufacturer of custom-made injection pens for pharmaceutical and biotech companies, and one of the leading suppliers of pen needles, is focusing future investments on its core business. With the strategic decision to prioritize investments for Ypsomed's own, innovative pen-systems, auto-injectors and pen-needles, Ypsomed will not re-start the distribution business for blood glucose monitoring devices. As a result of this decision, Ypsomed expects profitability to increase slightly faster and sales to remain growing between 15% and 25% over the next three years.

Go Back